
European Journal of Medicinal Chemistry p. 241 - 251 (1997)
Update date:2022-08-03
Topics:
Campiani
Nacci
Fiorini
De Filippis, Mp
Garofalo
Ciani
Greco
Novellino
Manzoni
Mennini
A number of new pyrrolobenzothiazepine derivatives and a pyrrolobenzothiazocine derivative have been synthesized and evaluated for their affinity towards the 'peripheral-type' benzodiazepine receptor (PBR). The new compounds were tested in rat cortex, a tissue expressing a high density of mitochondrial PBR. Some of the pyrrolobenzothiazepines exhibited IC50 values in the low nanomolar range as measured by the displacement of [3H]PK 11195 binding. Compound 4i was found to be the most potent ligand for this receptor in the pyrrolobenzothiazepine subgroup with an IC50 practically identical to that determined for PK 11195. Structure-affinity relationships (SARs) have been developed to elucidate the topology of the PBR binding site.
View MoreGuangzhou PI & PI Biotech Inc. Ltd.
Contact:+86-20-81716320
Address:13th Floor, Xinbao Technology Industrial Park, No. 2 Ruixiang Road, Huangpu District, Guangzhou,Guangdong,China
SuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Doi:10.1016/j.tetlet.2017.04.073
(2017)Doi:10.1021/jo034795e
(2003)Doi:10.1139/v67-351
(1967)Doi:10.1055/s-1997-800
(1997)Doi:10.1039/P19830001689
(1983)Doi:10.1021/om9703494
(1997)